In a Swedish real-world study, dialysis and nondialysis patients with high erythropoietin resistance index values had increased risk for major adverse cardiovascular events.
Patients on hemodialysis who received high-dose had similar rates of infection and rates of hospitalization for infection compared with those treated with low-dose IV iron, a secondary analysis of the PIVOTAL trial revealed.
In a study of kidney transplant recipients, mean hemoglobin levels rose from 10.69 g/dL prior to transplantation to 14.45 g/dL at 1 year after transplantation.
A study of stable dialysis patients receiving sucroferric oxyhydroxide found no significant changes in hemoglobin, ferritin level, and transferrin saturation.
Treatment with androgen deprivation therapy alone is associated with increased risks for anemia compared with radical prostatectomy alone, a study found.
